miRNA Pharmacogenomics: The New Frontier for Personalized Medicine in Cancer?
- 13 November 2012
- journal article
- review article
- Published by Informa UK Limited in Pharmacogenomics
- Vol. 13 (14), 1635-1650
- https://doi.org/10.2217/pgs.12.147
Abstract
In recent years pharmacogenomic research has highlighted several genetic biomarkers of treatment toxicity and efficacy, dealing with drug metabolism, transport and mechanism of action. More recently, polymorphisms in miRNA encoding genes, their targets or factors involved in their maturation are rising as new pharmacogenomic markers in cancer. miRNAs are brief ncRNAs involved in DNA translational control, with an effect on mRNA and protein-expression levels. The study of genetic polymorphisms in genes involved in miRNA translational control machinery could give innovative insights in pharmacogenomics. This review summarizes the most recent and promising results in the field and gives an overview of the future perspective of personalized cancer therapy.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (AIRC),
- Molecular Clinical Oncology (12214)
- European Research Council
- Programme ‘ideas’
- Italian Ministry of Education MIUR
This publication has 96 references indexed in Scilit:
- Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic ReviewJNCI Journal of the National Cancer Institute, 2012
- Pharmacogenetic tests in cancer chemotherapy: what physicians should know for clinical applicationThe Journal of Pathology, 2010
- A coding-independent function of gene and pseudogene mRNAs regulates tumour biologyNature, 2010
- Genetic variation in microRNA networks: the implications for cancer researchNature Reviews Cancer, 2010
- Has the revolution arrived?Nature, 2010
- Genotype-Driven Phase I Study of Irinotecan Administered in Combination With Fluorouracil/Leucovorin in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2010
- MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour typesEuropean Journal Of Cancer, 2010
- Pharmacogenomic Discovery Using Cell-Based ModelsPharmacological Reviews, 2009
- Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAsRNA, 2004
- Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAsNature Reviews Genetics, 2004